These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20837761)
1. Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea. Yum JH; Choi SH; Yong D; Chong Y; Im WB; Rhee DK; Lee K Antimicrob Agents Chemother; 2010 Dec; 54(12):5381-6. PubMed ID: 20837761 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of DA-7867, a novel oxazolidinone, against recent clinical isolates of aerobic and anaerobic bacteria. Yong D; Yum JH; Lee K; Chong Y; Choi SH; Rhee JK Antimicrob Agents Chemother; 2004 Jan; 48(1):352-7. PubMed ID: 14693566 [TBL] [Abstract][Full Text] [Related]
3. Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain. Betriu C; Morales G; Rodríguez-Avial I; Culebras E; Gómez M; López-Fabal F; Picazo JJ Antimicrob Agents Chemother; 2010 May; 54(5):2212-5. PubMed ID: 20176900 [TBL] [Abstract][Full Text] [Related]
4. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Locke JB; Hilgers M; Shaw KJ Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277 [TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria. Phillips OA; Rotimi VO; Jamal WY; Shahin M; Verghese TL J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385 [TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges. Brown SD; Traczewski MM Antimicrob Agents Chemother; 2010 May; 54(5):2063-9. PubMed ID: 20231392 [TBL] [Abstract][Full Text] [Related]
8. Activity of linezolid against anaerobic bacteria. Behra-Miellet J; Calvet L; Dubreuil L Int J Antimicrob Agents; 2003 Jul; 22(1):28-34. PubMed ID: 12842325 [TBL] [Abstract][Full Text] [Related]
9. Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent. Im WB; Choi SH; Park JY; Choi SH; Finn J; Yoon SH Eur J Med Chem; 2011 Apr; 46(4):1027-39. PubMed ID: 21292356 [TBL] [Abstract][Full Text] [Related]
10. Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines. Lemaire S; Van Bambeke F; Appelbaum PC; Tulkens PM J Antimicrob Chemother; 2009 Nov; 64(5):1035-43. PubMed ID: 19759040 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. Cercenado E; García-Garrote F; Bouza E J Antimicrob Chemother; 2001 Jan; 47(1):77-81. PubMed ID: 11152434 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci. Noskin GA; Siddiqui F; Stosor V; Hacek D; Peterson LR Antimicrob Agents Chemother; 1999 Aug; 43(8):2059-62. PubMed ID: 10428937 [TBL] [Abstract][Full Text] [Related]
13. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Citron DM; Merriam CV; Tyrrell KL; Warren YA; Fernandez H; Goldstein EJ Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492 [TBL] [Abstract][Full Text] [Related]
14. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections. Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005). Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: an area with a high prevalence of antibiotic resistance. Fang CT; Chang SC; Chen YC; Hsieh SM; Hsieh WC Int J Antimicrob Agents; 2001 Sep; 18(3):267-70. PubMed ID: 11673041 [TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of imipenem and 15 other antimicrobial agents against clinically important aerobic and anaerobic bacteria. Goldstein EJ; Citron DM Clin Ther; 1988; 10(5):487-515. PubMed ID: 2856592 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of linezolid and other antibiotics against Gram-positive bacteria from the major teaching hospitals in Kuwait. Al Sweih N; Mokaddas E; Jamal W; Phillips OA; Rotimi VO J Chemother; 2005 Dec; 17(6):607-13. PubMed ID: 16433190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]